Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In most endemic settings, relapses are estimated to substantially outnumber reinfections, with some suggesting that relapses account for up to 80% of recurrent infections in individuals who are not treated with radical cure [5].”
From Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins (2026) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stijnen, T., Hamza, T. H., & Özdemir, P. (2010) · Statistics in Medicine · doi:10.1002/sim.4040 · Cited by 757 · cited 1×
“vivax parasitemia in patients treated with primaquine versus those without was estimated using a Poisson regressionmodel with random study effects.(11,12) A random-effects model was used because the incidence rate ratio varies between geographic locations and studies.”
MethodBattle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31096-7 · Cited by 409 · cited 2×
“vivax malaria in these areas and likely high hypnozoite burdens.(1,10) FIGURE 2.”
Background
Research works printed but not linked: 30
- White, 2002, The assessment of antimalarial drug efficacy, Trends Parasitol, 18, 458, 10.1016/S1471-4922(02)02373-5 · DOI · Paper page
- Commons, 2018, The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis, Lancet Infect Dis, 18, 1025, 10.1016/S1473-3099(18)30348-7 · DOI · Paper page
- John, 2012, Primaquine radical cure of Plasmodium vivax: a critical review of the literature, Malar J, 11, 280, 10.1186/1475-2875-11-280 · DOI · Paper page
- Douglas, 2012, Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria, Adv Parasitol, 80, 271, 10.1016/B978-0-12-397900-1.00005-0 · DOI
- Imwong, 2007, Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites, J Infect Dis, 195, 927, 10.1086/512241 · DOI · Paper page
- Price, 2012, Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax, Trends Parasitol, 28, 522, 10.1016/j.pt.2012.08.005 · DOI
- Robinson, 2015, Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model, PLoS Med, 12, e1001891, 10.1371/journal.pmed.1001891 · DOI · Paper page
- Adekunle, 2015, Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo, PLoS Negl Trop Dis, 9, e0003595, 10.1371/journal.pntd.0003595 · DOI · Paper page
- White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar J, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
- Spittal, 2015, Meta-analysis of incidence rate data in the presence of zero events, BMC Med Res Methodol, 15, 42, 10.1186/s12874-015-0031-0 · DOI · Paper page
- Chu, 2018, Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria, Clin Infect Dis, 67, 1543, 10.1093/cid/ciy319 · DOI · Paper page
- Leslie, 2008, A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan, PLoS One, 3, e2861, 10.1371/journal.pone.0002861 · DOI
- Awab, 2017, Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial, Am J Trop Med Hyg, 97, 1782, 10.4269/ajtmh.17-0290 · DOI · Paper page
- Abreha, 2017, Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial, PLoS Med, 14, e1002299, 10.1371/journal.pmed.1002299 · DOI · Paper page
- Taylor, 2019, Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial, Lancet, 394, 929, 10.1016/S0140-6736(19)31285-1 · DOI · Paper page
- Rijal, 2019, Efficacy of primaquine in preventing short- and long-latency Plasmodium vivax relapses in Nepal, J Infect Dis, 220, 448, 10.1093/infdis/jiz126 · DOI · Paper page
- Taylor, 2019, Resolving the cause of recurrent Plasmodium vivax malaria probabilistically, Nat Commun, 10, 5595, 10.1038/s41467-019-13412-x · DOI · Paper page
- Nelwan, 2015, Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia, BMC Med, 13, 294, 10.1186/s12916-015-0535-9 · DOI
- Sutanto, 2013, Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia, Antimicrob Agents Chemother, 57, 1128, 10.1128/AAC.01879-12 · DOI
- Schmidt, 1977, Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose, Am J Trop Med Hyg, 26, 1116, 10.4269/ajtmh.1977.26.1116 · DOI
- Baird, 2018, Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria, JAMA Netw Open, 1, e181449, 10.1001/jamanetworkopen.2018.1449 · DOI · Paper page
- 2015, Guidelines for the Treatment of Malaria
- Gaedigk, 2017, Prediction of CYP2D6 phenotype from genotype across world populations, Genet Med, 19, 69, 10.1038/gim.2016.80 · DOI · Paper page
- Pukrittayakamee, 2000, Therapeutic responses to different antimalarial drugs in vivax malaria, Antimicrob Agents Chemother, 44, 1680, 10.1128/AAC.44.6.1680-1685.2000 · DOI · Paper page
- Pukrittayakamee, 1994, Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria, J Infect Dis, 169, 932, 10.1093/infdis/169.4.932 · DOI
- 2018, World Malaria Report 2018
- Pal, 2019, Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient, Am J Trop Med Hyg, 100, 213, 10.4269/ajtmh.18-0612 · DOI · Paper page
- Chu, 2018, Chloroquine versus dihydroartemisinin-piperaquine with standard high-dose primaquine given either for 7 days or 14 days in Plasmodium vivax malaria, Clin Infect Dis, 68, 1311, 10.1093/cid/ciy735 · DOI
- Lacerda, 2019, Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria, N Engl J Med, 380, 215, 10.1056/NEJMoa1710775 · DOI · Paper page
- Llanos-Cuentas, 2019, Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria, N Engl J Med, 380, 229, 10.1056/NEJMoa1802537 · DOI · Paper page
Cited by
Plasmodium—a brief introduction to the parasites causing human malaria and their basic biology
Sato, S. (2021) · Journal of Physiological Anthropology · doi:10.1186/s40101-020-00251-9 · Cited by 404
Siegel, S. V., Trimarsanto, H., Amato, R., Murie, K., Taylor, A. R., Sutanto, E., Kleinecke, M., Whitton, G., Watson, J. A., Imwong, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51015-3 · Cited by 30
Self-citationOsborne, A. A., Ruybal-Pesantez, S., Rai, A., Trimarsanto, H., Hoon, K. S., Piera, K., Kleinecke, M., Rumaseb, A., Sutanto, E., Thriemer, K., et al. (2026) · doi:10.64898/2026.11.12.765293
Self-citation
Metadata
- Authors
- Commons, R. J., Simpson, J. A., Watson, J., White, N. J., & Price, R. N.
- Affiliations
- Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia;
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia;
- Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
- Venue
- The American Journal of Tropical Medicine and Hygiene
- Published
- 2020-09-02
- Volume
- 103
- Issue
- 3
- Pages
- 1094-1099
- ISSN
- 0002-9637
- 1476-1645
- Cited by
- 147
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.4269/ajtmh.20-0186
- The paper
- Commons, R. J., Simpson, J. A., Watson, J., White, N. J., & Price, R. N. (2020). Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.20-0186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.